There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …

Background The COVID-19 pandemic has severely affected health systems and medical
research worldwide but its impact on the global publication dynamics and non-COVID-19 …

For three decades, the international Banff classification has been the gold standard for
kidney allograft rejection diagnosis, but this system has become complex over time with the …

Background Since the start of the COVID-19 outbreak, a large number of COVID-19-related
papers have been published. However, concerns about the risk of expedited science have …

Background Cross-species immunological incompatibilities have hampered pig-to-human
xenotransplantation, but porcine genome engineering recently enabled the first successful …

We previously established a six-gene–based blood score associated with operational tolerance
in kidney transplantation which was decreased in patients developing anti-HLA donor-…

Background Despite the increasing number of biomarker studies published in the transplant
literature over the past 20 years, demonstrations of their clinical benefit and their …

In late February 2021, the first cases of vaccine-induced thrombosis and thrombocytopenia (VITT)
were observed in patients after immunization with the ChAdOx1 nCoV-19 adenoviral …

C4d deposition in peritubular capillaries (PTC) reflects complement activation in antibody-mediated
rejection (ABMR) of kidney allograft. However, its association with allograft survival …

There is an unmet need for robust and clinically validated biomarkers of kidney allograft
rejection. Here we present the KTD-Innov study (ClinicalTrials. gov, NCT03582436), an …